We have used protein structure design technology to design pneumococcal protein antigens. In addition, we have developed novel recombinant strains to produce a new generation pertussis vaccine. We also developed a proprietary cell line to be used for viral vector production.
Copyright © ( 2017) CanSino Biologics Inc
For the record: 津ICP备14006666号-2